Risk of male breast cancer in users of testosterone 5a reductase inhibitors

H.L. Olsson, J. Lindahl, P. Broberg

Research output: Contribution to journalPublished meeting abstract

Original languageEnglish
JournalJournal of Clinical Oncology
Volume34
Issue numberSuppl 15
Publication statusPublished - 2016
Event2016 Annual Meeting of the American Society of Clinical Oncology - Chicago, IL, United States
Duration: 2016 Jun 32016 Jun 7

Subject classification (UKÄ)

  • Cancer and Oncology

Free keywords

  • adrenergic receptor blocking agent
  • androgen receptor
  • BRCA2 protein
  • steroid 5alpha reductase
  • cancer diagnosis
  • cancer registry
  • controlled study
  • death
  • diagnosis
  • drug exposure
  • gene inactivation
  • gene mutation
  • gynecomastia
  • human
  • logistic regression analysis
  • major clinical study
  • male
  • male breast cancer
  • population based case control study
  • proportional hazards model
  • prostate cancer
  • prostate hypertrophy
  • side effect

Cite this